Noticias de ALT_US

Noticias del mercado

Últimas noticias sobre ALT_US — 206 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ALT_US ✕ 206 resultados
05/04/2026 ALT_US — timothysykes.com
Altimmune Inc.’s New Price Target Ignites Investor Interest
04/04/2026 ALT_US — timothysykes.com ES ← EN
El objetivo de acciones de Altimmune aumenta a medida que el programa MASH gana impulso
01/04/2026 ALT_US — GuruFocus ES ← EN
Compra de información privilegiada: Gregory Weaver adquiere 10.000 acciones de Altimmu
01/04/2026 ALT_US — Stock Titan
Altimmune (ALT) CFO adds 10,000 shares in open-market stock purchase
01/04/2026 ALT_US — Stock Titan
Altimmune (NASDAQ: ALT) CEO adds 15,000 shares in open-market buy
27/03/2026 ALT_US — DirectorsTalk Interviews
Altimmune, Inc. (ALT) Stock Analysis: Exploring a Potential 462.50% Upside with Analyst Confidence
27/03/2026 ALT_US — Investing.com
Jefferies reiterates Buy on Altimmune stock, keeps $28 target
26/03/2026 ALT_US — TradingView
Altimmune Stock: Neutral Outlook With Big 2026 Catalysts
26/03/2026 ALT_US — Yahoo Finance
Altimmune Stock: Neutral Outlook With Big 2026 Catalysts
26/03/2026 ALT_US — Stock Titan
Vanguard subsidiaries disaggregate holdings; Altimmune (NASDAQ: ALT) showing 0 shares
26/03/2026 ALT_US — Yahoo Finance ES ← EN
ALT Stock y la carrera MASH 2026: agonistas duales frente a nuevos mecanismos
25/03/2026 ALT_US — Yahoo Finance
H.C. Wainwright Bullish on Altimmune (ALT) Amid Growing Focus on Treatments for Metabolic and Liver Diseases
25/03/2026 ALT_US — Insider Monkey ES ← EN
H.C. Wainwright se muestra optimista sobre Altimmune (ALT) en medio de un creciente enfoque en los tratamientos para enfermedades metabólicas y hepáticas
21/03/2026 ALT_US — Stock Titan
ALT SEC Filings - Altimmune 10-K, 10-Q, 8-K Forms
18/03/2026 ALT_US — MSN
Altimmune, Inc. (ALT) gains analyst support as pemvidutide advances
17/03/2026 ALT_US — Investing.com
H.C. Wainwright raises Altimmune stock price target on MASH focus
16/03/2026 ALT_US — GuruFocus ES ← EN
Altimmune (ALT) ve que HC Wainwright & Co. eleva el precio objetivo a 25 dólares | Noticias de acciones ALT
13/03/2026 ALT_US — DirectorsTalk Interviews
Altimmune, Inc. (ALT) Stock Analysis: Exploring a 378% Potential Upside Amidst Biopharmaceutical Innovation
12/03/2026 ALT_US — Seeking Alpha
Altimmune: The High Cost Of Going Solo (Rating Downgrade) (NASDAQ:ALT)
12/03/2026 ALT_US — Yahoo Finance
Altimmune Touts Pemvidutide Progress, Targets MASH Phase 3 Start and Q3 AUD Readout at Barclays Chat

Página 9 de 11

keyboard_arrow_up